| 21-06-25 | NattoPharma ASA : - Delisting | AQ |
| 21-06-15 | NattoPharma : Received application for delisting | AQ |
| 21-06-14 | NattoPharma : Annual General Meeting in NattoPharma ASA | AQ |
| 21-06-10 | NattoPharma : OSLO BØRS - SUSPENDED | AQ |
| 21-06-09 | NattoPharma ASA: Compagnie des Levures Lesaffre announces compulsory acquisition | AQ |
| 1 day | +2.35% |
| Manager | Title | Age | Since |
|---|---|---|---|
Kjetil Ramsøy
CEO | Chief Executive Officer | 54 | 2018-02-07 |
Robert Schrama
DFI | Director of Finance/CFO | - | 2020-03-08 |
Gunilla Traberg
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Frode Marc Bohan
CHM | Chairman | 58 | 2004-11-03 |
| Director/Board Member | 52 | 2011-01-31 | |
Kjetil Ramsøy
BRD | Director/Board Member | 54 | 2015-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.35% | +1.46% | - | - | 86.2M | ||
| -1.21% | -3.04% | +44.03% | +143.07% | 980B | ||
| -2.48% | -5.18% | +52.47% | +39.15% | 550B | ||
| -2.14% | -4.94% | +16.83% | +57.08% | 382B | ||
| +0.25% | -3.09% | +23.33% | +16.04% | 316B | ||
| +0.61% | -1.69% | +27.35% | +13.73% | 272B | ||
| +0.22% | -3.10% | +24.67% | +30.49% | 268B | ||
| +4.59% | +1.98% | -38.43% | -46.26% | 199B | ||
| -1.19% | -4.95% | +16.68% | +47.69% | 182B | ||
| -1.35% | -1.46% | +14.06% | +59.26% | 154B | ||
| Average | -0.04% | -3.02% | +20.11% | +40.03% | 366.93B | |
| Weighted average by Cap. | -0.78% | -3.68% | +29.49% | +63.31% |
Employees
18
Sector
Pharmaceuticals
















